Atlas Trials

Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer

Clinical trial NCT04990921 · RECRUITING

Trial details

NCT number
NCT04990921
Sponsor
University of Louisville
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2021-09-02
Primary completion
2031-07-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.